SpringWorks Therapeutics ...

NASDAQ: SWTX · Real-Time Price · USD
46.99
0.00 (0.00%)
At close: Jun 30, 2025, 3:59 PM

SpringWorks Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
49.09M 61.55M 49.3M 59.73M 21.01M 5.45M 5.59M 5.83M 5.56M 5.8M 838K 348K 5K n/a 121K 170K 230K
Cost of Revenue
3.53M 5.55M 3.34M 2.45M 1.93M 960K 933K 833K 539K 541K 498K 477K 380K 146K 362K 360K 367K
Gross Profit
45.56M 55.99M 45.96M 57.28M 19.07M 4.49M 4.65M 5M 5.02M 5.26M 340K -129K -375K -146K -241K -190K -137K
Operating Income
-80.54M -81.34M -57.94M -44.92M -93.93M -98.46M -84M -82.85M -77.7M -78.45M -71.74M -69.01M -61.47M -55.8M -40.9M -47.02M -29.76M
Interest Income
n/a 5.43M 6.22M 6.78M 7.57M 5.6M 5.66M 5.83M 5.56M 4.8M 912K 372K 198K 81K 179K 211K 227K
Pretax Income
-83.19M -77.3M -53.53M -39.92M -87.39M -94.32M -79.44M -77.92M -73.42M -74.18M -72.39M -69.05M -61.8M -56.07M -41.04M -47.01M -29.79M
Net Income
-83.19M -77.3M -53.53M -39.92M -87.39M -94.32M -79.44M -77.92M -69.14M -69.9M -71.48M -69.05M -61.8M -56.07M -41.04M -47.01M -29.79M
Selling & General & Admin
76.5M 77.1M 61.6M 57.84M 59.38M 59.84M 46.55M 46.99M 44.17M 40.53M 35.67M 30.99M 27.37M 26.45M 18.03M 14.93M 12.38M
Research & Development
49.59M 60.24M 42.3M 44.36M 53.62M 43.65M 37.45M 35.86M 33.52M 37.93M 36.07M 38.02M 34.1M 29.34M 22.87M 32.09M 17.38M
Other Expenses
n/a n/a n/a n/a n/a 373K -76K -98K -199K 153K -74K -24K -193K -56K -58K -41K 3K
Operating Expenses
126.1M 137.34M 103.9M 102.2M 113.01M 103.49M 84M 82.85M 77.7M 78.45M 71.74M 69.01M 61.47M 55.8M 40.9M 47.02M 29.76M
Interest Expense
-998K n/a n/a n/a n/a 4.28M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a -729K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
129.62M 142.89M 107.24M 104.65M 114.94M 103.91M 84M 82.85M 77.7M 78.45M 71.74M 69.01M 61.47M 55.8M 40.9M 47.02M 29.76M
Income Tax Expense
n/a n/a n/a n/a 685.72K n/a n/a -382K -4.28M -4.28M -912K -372K -198K -81K -179K -211K -227K
Shares Outstanding (Basic)
74.89M 74.13M 74.26M 74.12M 73.77M 73.49M 62.52M 62.46M 62.33M 62.42M 52.9M 49.07M 48.94M 48.74M 48.6M 48.42M 48.23M
Shares Outstanding (Diluted)
74.89M 74.13M 74.26M 74.12M 73.77M 73.49M 62.52M 62.46M 62.33M 62.42M 52.9M 49.07M 48.94M 48.74M 48.6M 48.42M 48.23M
EPS (Basic)
-1.11 -1.04 -0.72 -0.54 -1.18 -1.28 -1.27 -1.25 -1.11 -1.12 -1.35 -1.41 -1.26 -1.15 -0.84 -0.97 -0.62
EPS (Diluted)
-1.11 -1.04 -0.72 -0.54 -1.18 -1.28 -1.27 -1.25 -1.11 -1.12 -1.35 -1.41 -1.26 -1.15 -0.84 -0.97 -0.62
EBITDA
-80.54M -80.33M -57.06M -44.08M -93.2M -97.92M -83.5M -82.47M -77.45M -78.2M -71.53M -68.82M -61.36M -55.65M -40.78M -46.91M -29.65M
EBIT
n/a -77.3M -57.94M -44.92M -93.93M -98.46M -84M -82.85M -77.7M -78.45M -71.74M -69.01M -61.47M -55.8M -40.9M -47.02M -29.76M
Depreciation & Amortization
n/a 1.02M 878K 844K 729K 538K 933K 833K 539K 541K 498K 477K 380K 146K 362K 360K 367K